Clinical trial
Association Between a Pharmacogenetic Algorithm to Predict Blood Pressure Therapy With Blood Pressure Response to Anti-Hypertensive Therapy
NCT03292900 is registered in ClinicalTrials.gov with Geneticure, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Association Between a Pharmacogenetic Algorithm to Predict Blood Pressure Therapy With Blood Pressure Response to Anti-Hypertensive Therapy
- Lead sponsor
- Geneticure, LLC
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 1, 2018
- Completion date
- January 15, 2019
- Enrollment
- 758 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.